These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6434655)

  • 1. [Distribution of clinical isolates of Serratia marcescens by bacteriocin typing: a comparison of bacteriocin types between two distant university hospitals].
    Nasu M; Goto J; Goto Y; Tashiro T; Itoga T; Yamaguchi K
    Kansenshogaku Zasshi; 1984 Apr; 58(4):312-7. PubMed ID: 6434655
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriocin (marcescin) typing of clinically isolated Serratia marcescens.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):33-43. PubMed ID: 7015560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriocin typing of Serratia marcescens. A simplified system.
    Sproat D; Brown A
    Am J Clin Pathol; 1979 Feb; 71(2):172-6. PubMed ID: 371382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiological study of Serratia marcescens infections by bacteriocin typing.
    Nasu M; Goto J; Goto I
    Microbiol Immunol; 1982; 26(9):795-801. PubMed ID: 6759881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriocin typing and biotyping of clinical isolates of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):474-86. PubMed ID: 1755921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for differentiating among Serratia marcescens isolated from clinical specimens.
    Roemisch E; Kocka FE
    Am J Clin Pathol; 1976 Jul; 66(1):96-100. PubMed ID: 779447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriocin typing of Serratia marcescens isolates of known serotype-group.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):979-81. PubMed ID: 4555640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.
    Traub WH; Raymond EA; Startsman TS
    Appl Microbiol; 1971 May; 21(5):837-40. PubMed ID: 4930037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on group A (phage tail) bacteriocins of Serratia marcescens. V. Serological characterization of subgroup I and II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):521-7. PubMed ID: 779357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological studies of Serratia marcescens infections by bacteriocin (marcescin) typing.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):45-52. PubMed ID: 7015561
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens.
    Alonso R; Aucken HM; Perez-Diaz JC; Cookson BD; Baquero F; Pitt TL
    Epidemiol Infect; 1993 Aug; 111(1):99-107. PubMed ID: 8102336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Dec; 22(6):1058-63. PubMed ID: 4944804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typing of nosocomial strains of Serratia marcescens: comparison of restriction enzyme cleaved genomic DNA fragment (PFGE) analysis with bacteriocin typing, biochemical profiles and serotyping.
    Traub WH; Eiden A; Leonhard B; Bauer D
    Zentralbl Bakteriol; 1996 Jun; 284(1):93-106. PubMed ID: 8837373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic variation of clinical Serratia marcescens isolates repeatedly recovered from individual patients.
    Traub WH; Eiden A; Leonhard B; Bauer D
    Zentralbl Bakteriol; 1996 Jun; 284(1):124-35. PubMed ID: 8837376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriocin (marcescin) typing of Serratia marcescens. II. The distribution of Serratia marcescens in hospital and its isolated cases by bacteriocin (marcescin) typing (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1978 Jun; 52(6):183-9. PubMed ID: 101627
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative biotyping, bacteriocin typing, and serogrouping (O-antigens) of Serratia liquefaciens.
    Traub WH
    Zentralbl Bakteriol; 1991 Jun; 275(2):200-10. PubMed ID: 1718303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two methods for bacteriocin typing of Serratia marcescens.
    Lai PS; Ngeow YF; Puthucheary SD; Wang CW
    J Clin Microbiol; 1983 Jan; 17(1):1-6. PubMed ID: 6338029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on the epidemiology of Sarratia marcescens using bacteriocin typing].
    Fritsche D; Dostal C; Spieckermann C
    Zentralbl Bakteriol Orig A; 1973 May; 223(4):513-9. PubMed ID: 4146827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.